Provenance du réseau au premier degré de Peter Goettel
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Berlin Cures Holding AG
 Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023.
4
| Subsidiary | Biotechnology | 4 |
Berlin Cures GmbH
 Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Berlin Cures GmbH engages in the development and production of a drug for the treatment of chronic heart failure. The company was founded on September 9, 2014 and is headquartered in Berlin, Germany.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Berlin Heals GmbH
 Berlin Heals GmbH Medical SpecialtiesHealth Technology Berlin Heals GmbH is a life science company that was founded in 2014 with the mission to develop its proprietary c-mic technology to treat heart failure. The company is based in Berlin, Germany, and has subsidiaries in Switzerland. The German company has developed a novel implantable electroceutical device called "c-mic," which is a small implantable device that propagates reverse remodeling of the cardiac muscle tissue. The c-mic device is a breakthrough near-curative treatment for patients with systematic and refractory heart failure. The company intends to test the efficacy of its technology with patients suffering from heart failure with preserved ejection fractions (HFPEF-patients). The CEOs of the company are Peter Goettel and Johannes Müller.
1
| Holding Company | Medical Specialties | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter Goettel via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HUMANIGEN, INC. | Biotechnology | Director/Board Member | |
| MEDIGENE AG | Biotechnology | Corporate Officer/Principal | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Operating Officer | |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| FLERIE INVEST AB | Pharmaceuticals: Major | Founder | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member | |
Berlin Heart GmbH
 Berlin Heart GmbH Medical SpecialtiesHealth Technology Berlin Heart AG develops, manufactures and markets mechanical cardiac support systems. Its systems are used as life-savers for persons with a severely diseased heart. Its products INCOR, EXCOR, and EXCOR pediatric cover the range of medical indication for all ages, from the newborn to the adult. The company was founded in 2000 and is headquartered in Berlin, Germany. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Universität Ulm | College/University | Doctorate Degree | |
Novartis Pharma SAS
 Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France. | Pharmaceuticals: Major | Chief Executive Officer | |
| Karlsruher Institut für Technologie | College/University | Doctorate Degree | |
| Schiller International University (France) | College/University | Masters Business Admin | |
| OMEGA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Berlin Heals Holding AG
 Berlin Heals Holding AG Medical SpecialtiesHealth Technology Part of Berlin Heals GmbH, the company is a medical device company based in Zug, Switzerland. The Swiss company develops implantable medical devices for the cure of heart failure. The company was founded in 2014 by Johannes Müller, Marko Bagaric, Peter Goettel. Marko Bagaric has been the CEO since 2014. | Medical Specialties | Founder Founder | |
| Rainer Boehm GmbH | Founder | ||
| BioCopy AG | Director/Board Member |
Statistiques
Internationale
| Suisse | 6 |
| Allemagne | 5 |
| Etats-Unis | 4 |
| France | 4 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 11 |
| Consumer Services | 4 |
| Commercial Services | 3 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 8 |
| Founder | 6 |
| Chief Executive Officer | 6 |
| Chief Tech/Sci/R&D Officer | 4 |
| Chairman | 4 |
Relations les plus connectées
| Insiders | |
|---|---|
| Rainer Boehm | 12 |
| Johannes Müller | 5 |
| Oliver von Stein | 5 |
| Marko Bagaric | 4 |
- Bourse
- Insiders
- Peter Goettel
- Connexions Sociétés
